ReviewClinical microbiology reviews1996
Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans.
Review in Clinical microbiology reviews, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed, 169 citations in OpenAlex.
- Mycobacterium haemophilum and lymphadenitis in children.Emerging infectious diseases · 2005Trial
- CutaneousClinical case reports · 2026Article
- Expanding the Clinical Spectrum ofOpen forum infectious diseases · 2026Article
- Case Report:Frontiers in medicine · 2026Article
- Article
- A Systemic Lupus Erythematosus Patient with CutaneousAnnals of dermatology · 2023Article
- [Two severe cases of disseminated cutaneous nontuberculous mycobacteriosis due to Mycobacterium haemophilum].Zeitschrift fur Rheumatologie · 2023Article
- Case report: SubcutaneousFrontiers in medicine · 2023Article
- Osteomyelitis due toIDCases · 2023Article
- Construction and Analysis of the Complete Genome Sequence of Leprosy Agent Mycobacterium lepromatosis.Microbiology spectrum · 2022Article
- Disseminated cutaneousBMJ case reports · 2022Article
- Fatal disseminatedJournal of clinical tuberculosis and other mycobacterial diseases · 2020Article
- Clinical image: chronic skin ulcers in a patient with rheumatoid arthritis on immunosuppressant therapy.Clinical rheumatology · 2020Article
- Meningomyeloencephalitis secondary to Mycobacterium haemophilum infection in AIDS.Acta neuropathologica communications · 2020Article
- Rare infection in patient with rheumatoid arthritis treated with adalimumab.BMJ case reports · 2019Article
- Skin and Soft Tissue Infections Due to Nontuberculous Mycobacteria.Current infectious disease reports · 2018Review
- Late-onset postoperative Mycobacterium haemophilum endophthalmitis masquerading as inflammatory uveitis: a case report.BMC infectious diseases · 2018Article
- The Brief Case: Disseminated Mycobacterium haemophilum Infection in a Kidney Transplant Recipient.Journal of clinical microbiology · 2018Article
- Fifteen-year clinical experience withJournal of clinical tuberculosis and other mycobacterial diseases · 2017Review
- Disseminated Mycobacterium haemophilum infection in a renal transplant recipient.BMJ case reports · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reports of the association of Mycobacterium haemophilum with disease in humans have greatly increased. At least 64 cases have now been reported, with symptoms ranging from focal lesions to widespread, systemic disease. The organism is now known to cause primarily cutaneous and subcutaneous infection, septic arthritis, osteomyelitis, and pneumonitis in patients who are immunologically compromised and lymphadenitis in apparently immunocompetent children. Underlying conditions in the compromised patients have included AIDS; renal, bone marrow, and cardiac transplantation; lymphoma; rheumatoid arthritis; marrow hypoplasia; and Crohn's disease. Reports have originated from diverse geographic areas worldwide. The epidemiology of M. haemophilum remains poorly defined; there appears to be a genetic diversity between strains isolated from different regions. The organism is probably present in the environment, but recovery by sampling has not been successful. M. haemophilum has several unique traits, including predilection for lower temperatures (30 to 32 degrees C) and requirement for iron supplementation (ferric ammonium citrate or hemin). These may in the past have compromised recovery in the laboratory. Therapy has not been well elucidated, and the outcome appears to be influenced by the patient's underlying immunosuppression. The organisms are most susceptible to ciprofloxacin, clarithromycin, rifabutin, and rifampin. Timely diagnosis and therapy require communication between clinician and the laboratory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.